BaseLaunch Information

BaseLaunch partners with scientists and entrepreneurs to build exceptional biotech companies. It serves as a platform to launch early-stage biotech ventures from inception through to Series A funding, providing financing and supporting all aspects of company creation and growth. BaseLaunch partners with leading global pharma and biotech companies and a venture fund – AbbVie, Roche, Novo Nordisk, Johnson & Johnson, CSL, Pfizer, Takeda, and Pureos Bioventures, which also feed into the pool out of which BaseLaunch funds ventures. Domain and regional partners include KPMG, Vossius & Partner, Walder Wyss attorneys at law, WuXi AppTec, Lonza, Wuxi Biologics, BioDuro, VISCHER, Hoffmann & Partner, Catalent as well as the Switzerland Innovation Park Basel Area. BaseLaunch is operationally run and financed by Basel Area Business & Innovation. Since 2018, BaseLaunch supported ventures have raised in total over US$ 1.5 billion. Harnessing the Basel area’s unique position as a global life sciences hub, as well as its rising popularity among investors, BaseLaunch is looking to attract the next generation of breakthrough companies. Interested groups can find more information at www.baselaunch.ch.